Table 1.
Aggregation: Adrenaline | Aggregation: Adrenaline ± platelets | Aggregation: Adrenaline ± ADP | Activation: Adrenaline ± ADP | Aggregation: Pooled data | |
---|---|---|---|---|---|
N | 10 | 10 | 10 | 10 | 30 |
Age (years) |
58 (1.9), range 50‐66 |
66 (3.3), range 51‐82 |
65 (3.7), range 46‐80 |
65 (5), range 38‐84 |
63 (1.9), range 46‐82 |
Gender (male) | 10 (100%) | 7 (70%) | 8 (80%) | 8 (80%) | 25 (83.3%) |
Platelet count (×109 L−1) | 227 (19.7) | 233 (19.4) | 280 (39.3) | 211 (34.3) | 247 (16.4) |
Hemoglobin (g L−1) | 145 (3.9) | 142 (3.9) | 136 (7.6) | 145 (5.7) | 141 (3.1) |
Serum creatinine (μmol L−1) | 93.8 (2.7) | 80.9 (6.2) | 98.4 (13.2) | 91.1 (5.9) | 91.4 (5.0) |
BMI (kg m−2) | 27.6 (1.4) | 26.6 (1.4) | 27.4 (0.9) | 27.1 (1.1) | 27.2 (0.8) |
Diabetes mellitus | 0 | 0 | 2 (20%) | 2 (20%) | 2 (6.7%) |
Type of ACS | |||||
STEMI | 7 (70%) | 1 (10%) | 5 (50%) | 5 (50%) | 13 (43.3%) |
NSTEMI | 2 (20%) | 6 (60%) | 4 (40%) | 5 (50%) | 12 (40%) |
Unstable angina | 1 (10%) | 3 (30%) | 1 (10%) | 0 | 5 (16.7%) |
Medicationa | |||||
Fondaparinux | 1 (10%) | 3 (30%) | 0 | 2 (20%) | 4 (13.3%) |
Heparin | 0 | 2 (20%) | 0 | 0 | 2 (6.7%) |
Simvastatin | 0 | 0 | 1 (10%) | 1 (10%) | 1 (3.3%) |
Atorvastatin | 9 (90%) | 10 (100%) | 8 (80%) | 8 (80%) | 27 (90%) |
ACS, acute coronary syndrome; BMI, body mass index; STEMI, ST‐segment elevation myocardial infarction; NSTEMI, non‐ST‐segment elevation myocardial infarction.
Within 24 hours of sampling.